Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - CAPITAL EXPENDITURES
Capital Expenditures IOVA - Iovance Biotherapeutics, Inc.
-22.3 M
LAST VALUE
22.98%
2 YEAR CAGR
-79.44%
5 YEAR CAGR
-111.06%
10 YEAR CAGR